Phase III study of immediate compared with delayed docetaxel after front-line therapy with gemcitabine plus carboplatin in advanced non-small-cell lung cancer - Fidias, P M; Dakhil, S R; Lyss, A P (J Clin Oncol, 2009)
, et al.